Literature DB >> 25366887

["Bridge to recovery"- implantation of an Impella® CP in infarct-related cardiogenic shock].

G Fröhlich1, A Pibernik, M Ferrari.   

Abstract

We present the case of a 43-year-old man with the diagnosis of a posterior and anterior wall infarction who was taken to our institution after prolonged cardioplumonary resuscitation. Cardiac catheterization showed thrombotic occlusion of the LAD and a subtotal stenosis of the right coronary artery. Both lesions were revascularized by PCI. Despite catecholamine infusion, the patient developed severe cardiogenic shock with multiorgan dysfunction syndrome under therapeutic hypothermia. Thus, an Impella® CP, a percutaneous left ventricular assist device (LVAD), was implanted. Due to effective LVAD support, it was possible to wean and remove the device after 75 h of support. The impaired left ventricular ejection fraction and wall-motion abnormalities which were present on day 1 achieved complete recuperation on day 14. The patient was discharged without any neurological deficits.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25366887     DOI: 10.1007/s00063-014-0426-4

Source DB:  PubMed          Journal:  Med Klin Intensivmed Notfmed        ISSN: 2193-6218            Impact factor:   0.840


  27 in total

Review 1.  Myocardial 'stunning' in man.

Authors:  R Bolli
Journal:  Circulation       Date:  1992-12       Impact factor: 29.690

2.  Cardiopulmonary resuscitation by bystanders with chest compression only (SOS-KANTO): an observational study.

Authors: 
Journal:  Lancet       Date:  2007-03-17       Impact factor: 79.321

Review 3.  [Therapy of cardiogenic shock after myocardial infarction].

Authors:  M Ferrari; H R Figulla
Journal:  Internist (Berl)       Date:  2008-09       Impact factor: 0.743

Review 4.  Prognostication of neurologic outcome in cardiac arrest patients after mild therapeutic hypothermia: a meta-analysis of the current literature.

Authors:  M J A Kamps; J Horn; M Oddo; J E Fugate; C Storm; T Cronberg; C A Wijman; O Wu; J M Binnekade; C W E Hoedemaekers
Journal:  Intensive Care Med       Date:  2013-06-26       Impact factor: 17.440

5.  Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 month results of a randomised, open-label trial.

Authors:  Holger Thiele; Uwe Zeymer; Franz-Josef Neumann; Miroslaw Ferenc; Hans-Georg Olbrich; Jörg Hausleiter; Antoinette de Waha; Gert Richardt; Marcus Hennersdorf; Klaus Empen; Georg Fuernau; Steffen Desch; Ingo Eitel; Rainer Hambrecht; Bernward Lauer; Michael Böhm; Henning Ebelt; Steffen Schneider; Karl Werdan; Gerhard Schuler
Journal:  Lancet       Date:  2013-09-03       Impact factor: 79.321

6.  Recovery of ventricular function after myocardial infarction in the reperfusion era: the healing and early afterload reducing therapy study.

Authors:  S D Solomon; R J Glynn; S Greaves; U Ajani; J L Rouleau; F Menapace; J M Arnold; C Hennekens; M A Pfeffer
Journal:  Ann Intern Med       Date:  2001-03-20       Impact factor: 25.391

Review 7.  Assessing prognosis following cardiopulmonary resuscitation and therapeutic hypothermia-a critical discussion of recent studies.

Authors:  Frank Thömke
Journal:  Dtsch Arztebl Int       Date:  2013-03-01       Impact factor: 5.594

8.  Presentation, management, and outcome of out of hospital cardiopulmonary arrest: comparison by underlying aetiology.

Authors:  J P Pell; J M Sirel; A K Marsden; I Ford; N L Walker; S M Cobbe
Journal:  Heart       Date:  2003-08       Impact factor: 5.994

9.  Hemodynamic effects of a continuous infusion of levosimendan in critically ill patients with cardiogenic shock requiring catecholamines.

Authors:  G Delle Karth; A Buberl; A Geppert; T Neunteufl; M Huelsmann; C Kopp; M Nikfardjam; R Berger; G Heinz
Journal:  Acta Anaesthesiol Scand       Date:  2003-11       Impact factor: 2.105

10.  A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction.

Authors:  Melchior Seyfarth; Dirk Sibbing; Iris Bauer; Georg Fröhlich; Lorenz Bott-Flügel; Robert Byrne; Josef Dirschinger; Adnan Kastrati; Albert Schömig
Journal:  J Am Coll Cardiol       Date:  2008-11-04       Impact factor: 24.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.